Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0001193125-26-059332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | 2026-02-17 | KPTI | Poulton Stuart | EVP, Chief Development Off | S - Sale | $8.63 | -378 | 99.4K | -0.4% | -$3,262 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-17 | S | D | 378 | $8.63 | 99,429 | D | — | — |